NCT06213285View on ClinicalTrials.gov

APPEND-CT Registry

Enrolling by invitationOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

February 14, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

January 31, 2025

Conditions
Stroke, IschemicDevice Related ThrombosisAtrial Fibrillation
Interventions
DEVICE

Watchman FLX left atrial appendage occlusion

Early (30-120 days) CT follow-up after Watchman FLX LAAO

Trial Locations (2)

8200

Aarhus University Hospital, Aarhus

55901

Mayo Clinic, Rochester

Sponsors
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

Boston Scientific Corporation

INDUSTRY

lead

Aarhus University Hospital

OTHER

NCT06213285 - APPEND-CT Registry | Biotech Hunter | Biotech Hunter